Unidade de investigación
Servicio
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (4)
2022
-
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study
BMJ open, Vol. 12, Núm. 3, pp. e051378
-
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24
2021
-
A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users
Scientific Reports, Vol. 11, Núm. 1
-
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073